Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

MLA

Boekel, L., et al. “Antibody Development and Disease Severity of COVID-19 in Non-Immunised Patients with Rheumatic Immune-Mediated Inflammatory Diseases: Data from a Prospective Cohort Study.” Rheumatic & Musculoskeletal Diseases Open, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366778916&authtype=sso&custid=ns315887.

APA

Boekel, L., Hooijberg, F., Vogelzang, E. H., Besten, Y. R., Leeuw, M. de, Atiqi, S., Vollenhoven, R. F. van, Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Dijkshoorn, B., Bakhlakh, S., Crooijmans, J. J., Voskuyl, A., Horst-Bruinsma, I. E. van der, Lems, W., Kuijpers, T. W., Ham, S. M. van, Wieske, L., … Wolbink, G. (2022). Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. Rheumatic & Musculoskeletal Diseases Open.

Chicago

Boekel, L., F. Hooijberg, E.H. Vogelzang, Y.R. Besten, M. de Leeuw, S. Atiqi, R.F. van Vollenhoven, et al. 2022. “Antibody Development and Disease Severity of COVID-19 in Non-Immunised Patients with Rheumatic Immune-Mediated Inflammatory Diseases: Data from a Prospective Cohort Study.” Rheumatic & Musculoskeletal Diseases Open. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366778916&authtype=sso&custid=ns315887.